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Advances in detection sensitivity of ion chromatography have revealed widespread contamination of ground and drinking water with perchlorate (ClO 4 À ) across the United States (Motzer, 2001; Urbansky and Schock, 1999 ; U.S. Environmental Protection Agency, 2003) . The bulk of this contamination is associated with the use of ammonium perchlorate (NH 4 ClO 4 ) as an oxidizing agent in missile and rocket fuel. Ammonium perchlorate is also used in pyrotechnics (fireworks) and air bag inflators. The salt is readily soluble in water, and its dissociation product, the perchlorate anion (ClO 4 À ), is very stable under environmental conditions and very mobile in most media (Motzer, 2001) .
Perchlorate is not metabolized in the body (Anbar et al., 1959; Yu et al., 2002) . However, because ClO 4 À has a similar hydrated ionic radius and carries the same charge as iodide (I À ), it is able to affect biological systems by inhibiting I À uptake into the thyroid by the sodium-iodide symporter (NIS) (Anbar et al., 1959; Brown-Grant and Pethes, 1959) . While it is known that ClO 4 À competes with I À for NIS binding sites, whether ClO 4 À is actually translocated into thyrocytes is the subject of debate (Eskandari et al., 1997; Riedel et al., 2001) . The weight of evidence at this time, however, suggests ClO 4 À is a competitive inhibitor of thyroid I À uptake, replacing I À as a substrate of NIS and crossing the basolateral membrane (Clewell et al., 2004 , Van Sande et al., 2003 . Reduced I À uptake may lead to a disturbance in the first stage of normal thyroid hormone genesis. Hence, there is reasonable concern that chronic exposure to low levels of ClO 4 À in drinking water could induce thyroid hormone deficiencies and subsequent thyroid disorders.
NIS resides in the basolateral membrane of thyroid epithelial cells and simultaneously transports two Na 1 and one I À ion from extracellular fluid (plasma) into the thyroid epithelial cell (Spitzweg et al., 2000) . NIS is expressed in the thyroid and other tissues including the GI tract, skin, mammary tissue, and placenta. However, only in the thyroid is I À organified to form thyroid hormones and iodinated proteins (Ajjan et al., 1998; Spitzweg et al., 1998) . Thyroid hormone homeostasis is maintained through a complex feedback mechanism. A drop in circulating serum thyroid hormone levels signals the pituitary to produce more thyroid stimulating hormone (TSH), which in turn stimulates NIS expression.
In rats, a decrease in free thyroxine (fT 4 ) and subsequent increase in TSH occur quickly (within one day) after acute ClO 4 À exposures Yu et al., 2002) . In humans, thyroid hormone conservation is more efficient, although thyroid hormone status is very dependant on the iodine status and life stage under consideration. Little or no significant change in T 4 , fT 4 , and TSH was seen in adults after 2 weeks of controlled exposure to ClO 4 À via drinking water at 0.007 to 0.05 mg/kg/day (Greer et al., 2002) and 0.14 mg/kg/day (Lawrence et al., 2000) , despite significant levels of thyroid I À uptake inhibition. However, significant drops in fT 4 , intrathyroidal iodine, as well as an increase in serum thyroglobulin (Tg) have been reported in humans after high levels of exposure (900 mg/day) for 4 weeks (Brabant et al., 1992) . The dynamics of thyroid hormone homeostasis is very different for a late gestation fetus or neonate. Empirical measurement of intrathyroidal stores of thyroid hormone in human fetuses and neonates have shown that the amount of thyroid hormone stored in the colloid is less than that required for a single day (van den Hove et al., 1999) . The extent of chronic low-level ClO 4 À exposure required to cause significant hormone deficiencies in humans is not yet known. Thus, the question facing risk assessors and regulatory agencies is: what concentrations of perchlorate could be considered problematic? It is known that I À deficiency during the fetal and neonatal period affects physical and mental development (Laurberg et al., 2000; Porterfield, 1994) . In the adult, effects of I À deficiency are less dramatic. Clinical and subclinical hypothyroidism is often overlooked due to the vague symptoms associated with the condition. Yet, hypothyroidism occurs in over 10% of older women and is associated with cognitive impairment (Volpato et al., 2002) . The development of hyperthyroidism, especially in multinodular goiters with autonomous nodules, is also associated with long-term mild to moderate I À deficiency in adults. Hyperthyroidism is also often overlooked in the elderly and, if left untreated, may lead to cardiac arrhythmias, impaired cardiovascular reserves, osteoporosis, and other abnormalities (Laurberg et al., 2000) . Therefore, perchlorate-induced I À deficiency may represent a public health concern not only during perinatal development, but also in the elderly and subpopulations with already compromised thyroid function.
In order to better understand the effect of occupational and environmental exposure to perchlorate on the hypothalamuspituitary-thyroid (HPT) axis, a few studies have been performed that directly correlate hormone changes to quantitative perchlorate doses. In two occupational health studies at U.S. ClO 4 À production facilities, workers were exposed to ammonium perchlorate (NH 4 ClO 4 ) dust in the air. Perchlorate exposure levels were estimated from monitoring breathing zone air over full work shifts (Gibbs et al., 1998; . Gibbs and coauthors categorized exposure groups based on job tasks and air monitoring results. Controls, selected from an associated plant, were not exposure free, but had exposures estimated to be several orders of magnitude below any of the 'exposed' groups. The researchers found no elevation in pre-and post-shift serum TSH, and no drop in serum free thyroxine (fT 4 ) among any of the exposed workers. In the study by , control or 'comparison group' subjects worked at the same facility but at unrelated processes and were believed to have very low exposure to perchloratecontaminated particulates. Daily perchlorate doses were estimated from breathing zone air monitoring of respirable particulates over full work shifts and by urinary measurements. No significant differences in triiodothyronine (T 3 ) and T 4 were reported between the exposure and comparison groups. However, the mean pre-and post-shift urine perchlorate measurements from the comparison group averaged, respectively, 64% and 22% of those from the lowest 'exposed' group. Ecological epidemiological studies on neonatal screening data from California, Nevada, and Arizona health departments have resulted in conflicting data. Studies by Lamm and Doemland (1999) and Li et al. (2000) showed no increase in incidence of congenital hypothyroidism or decrease in neonatal T 4 associated with ClO 4 À in drinking water up to 15 mg/l. In contrast, the studies of Schwartz (2001) and Brechner et al. (2000) both found effects on newborn thyroid hormones from exposures at similar environmental levels (1 to 15 mg/l). A retrospective study of school-age children and newborns in three Chilean cities with drinking water concentrations of 54, 5-7, and 100-120 mg ClO 4 À /l revealed significantly higher fT 4 but normal TSH in the two cities with highest ClO 4 À concentrations (Crump et al., 2000) , a result opposite to what might be expected. While dietary I À levels of the three Chilean populations were within normal range, their urinary excretion levels were increased. Hence, the increase in fT4 may represent an adaptive effect.
These human epidemiological studies, while informative as to the specific populations in which they were performed, have been of limited utility in aiding the extrapolation across species, populations, or exposure scenarios. Furthermore, differences in route of exposure and lack of adequate adjustment for particle dosimetry (Gibbs et al., 1998; , ambiguities in level of exposure and exposure misclassification (Crump et al., 2000; Gibbs et al., 1998; make these data sets of questionable use for predictive purposes (U.S. Environmental Protection Agency, 2003) . Laboratory animal data, however, have indicated effects on developmental neurotoxicity, thyroid hormones, and thyroid histopathology that have raised concern for human health at various life stages (U.S. Environmental Protection Agency, 2003) . Unfortunately, measurements of critical neuropsychological effects, such as IQ or physical development in children exposed to ClO À 4 in drinking water, are not available. Therefore, to assist in evaluating the potential effects of ClO 4 À in humans, a human PBPK model corresponding to those developed for the male, pregnant, and fetal rat (Clewell et al., 2003a,b; Merrill et al., 2003) is proposed. When used together, these models allow the entire body of ClO 4 À literature (both animal and human) to be used to more effectively predict perchlorate-induced changes in thyroid I À uptake across species, life-stage, and exposure doses.
The focus of this and ongoing modeling efforts with ClO 4 À is to integrate animal and human data and to evaluate quantitatively the impact of chronic exposure to perchlorate-contaminated drinking water. This physiological model focuses on the first step in the process, perchlorate-induced inhibition of I À uptake in the thyroid. The model describes the kinetics and distribution of both radioactive I À and ClO 4 À in healthy adult humans and simulates the subsequent inhibition of thyroid uptake of radioactive I À by ClO 4 À . Distinct thyroid hormones and their regulatory feedback are not yet incorporated into the model structure, although free and organified I À (representing combined thyroid hormones and nonhormonal iodoproteins) in plasma and thyroid secretions are described separately. Hence, in addition to predicting perchlorate's ability to inhibit thyroid uptake of radioactive I À , the model represents significant work toward establishing a basis for quantifying the effect of ClO 4 À on the total amount of circulating thyroid hormones.
METHODS
Supporting studies. As mentioned above, the proposed model was developed concurrently with other PBPK models, which describe several life stages in the rat, and shares several parameter values for which human data do not exist. However, whenever available, human data, obtained from Hays and Solomon (1965) , Degroot et al. (1971) , and Greer et al. (2002) , were used for establishing I À and ClO 4 À parameters. Hays and Solomon (1965) À . An additional set of thirteen subjects were later exposed in a more limited 'uptake' study. Six women and one man were tested in this 'uptake' study at a lower dose of (0.007 mg/kg-day), and two additional subjects each were tested at the previous doses. In this 'uptake study,' serum samples were taken on days 8 and 14 and urine collected on day 14. RAIU measurements were also made in these subjects following 123 I ingestion on the day prior to perchlorate exposure (baseline measurements) and at 9 A.M. on exposure day 14 and post-exposure day 1 (Greer et al., 2002) . The age of the subjects in both the 'main' and 'uptake' studies ranged from 18 to 57 years with a mean of 38 (SD 6 12) years.
The serum and urine samples were shipped to the Air Force Research Lab (AFRL/HEST) at Wright Patterson Air Force Base for ClO 4 À analyses. The analytical method for the analyses was similar to that described in Narayanan et al. (2003) . However, an important distinction between the analytical method used in this study and that of Narayanan and colleagues is the mobile phase concentration used. These concentrations were 80 mM NaOH for serum and from 60 to 120 mM NaOH for urine (depending on the sample). The range in mobile phase concentrations for the urine samples was required to attain proper sensitivity. Eight-and 24-h thyroid RAIU values were provided directly from the measurements of Greer et al.
Model validation studies. Iodide model parameters were validated through predictions of protein-bound iodine (PBI) data from Scott and Reilly (1954 Eichler (1929) , and Kamm and Drescher (1973) . In these studies healthy males received a single oral dose of potassium perchlorate, ranging from 635 to 1400 mg ClO 4 À .
Predictions of ClO 4 -induced inhibition of thyroid I
À uptake were validated with the RAIU data of Greer et al. (2002) and ClO 4 À discharge data by Gray et al. (1972) . Lastly, the model's ability to predict thyroid I À uptake and inhibition in hyperthyroid individuals was tested against data from Stanbury and Wyngaarden (1952) . Model structure. The described PBPK model ( Fig. 1 ) conforms to the structure of the concurrently developed model for the male rat (Merrill et al., 2003) , with the exception of the newly added plasma subcompartment for bound I À , included for completeness. For both I À and ClO 4 À , tissues containing NIS (thyroid, skin, and stomach) were described as compartments with nonlinear saturable uptake kinetics (Anbar et al., 1959; Chow et al., 1969; Kotani et al., 1998; Perlman et al., 1941; Slominski et al., 2002; Wolff, 1998) . Other NIScontaining tissues, such as the salivary glands, choroid plexus, ovaries, mammary glands, and placenta (Brown-Grant, 1961; Honour et al., 1952; Spitzweg et al., 1998) were lumped with the slowly and richly perfused tissues, as either their anion pools are too small to significantly affect plasma levels (Cserr et al., 1980) , or they are not applicable to the nonpregnant human. In development of the model, a quantitative sensitivity analysis showed no significant effect of either the gastric or thyroid uptake parameters on serum levels. Since the organ volumes are small and relative activity of NIS in the choroids plexus and salivary glands, etc. are even lower, we would expect these tissues to also have little to no effect on plasma concentrations. The stomach includes three subcompartments for capillary blood, stomach wall, and contents. Skin is described with two subcompartments for capillary blood and skin tissue. The thyroid is described with three subcompartments to describe the disposition of ClO 4 À in the gland representing stroma, follicle, and (Clewell et al., 2004; Merrill et al., 2003) . Unlike ClO 4 À , which eventually diffuses from the thyroid back into systemic circulation unchanged (Anbar et al., 1959; Wolff, 1998) , most I À is quickly incorporated into monoiodothyrosine (MIT) and diiodothyrosine (DIT) in the thyroid follicle, which in turn combine to form thyroid hormones, triiodothyrosine (T 3 ) and thyroxine (T 4 ), which are then secreted into circulating blood. Endogenous iodine content in the normal thyroid is about 10,000 mg, of which greater than 90% is organic and 5-10% is free (Berman, 1967) . Therefore, a fourth subcompartment, representing all 'incorporated' I À in the entire thyroid (i.e., total incorporated I À in the stroma, follicle, and lumen) is included. The incorporation of free I À into thyroid hormones and iodinated precursors, and the subsequent secretion of incorporated I À from the thyroid into venous blood were modeled with first-order rates. Passive diffusion is governed by the electrochemical gradients formed by the variation in anion concentration across thyroid subcompartments and wasdescribed with permeability area cross products and partition coefficients, (symbolized as small arrows in Fig. 1 ). Active uptake at NIS sites and between the thyroid follicle and lumen was describe using Michaelis-Menten (M-M) parameters ( 
When radioactive I
À is given orally, nothing is available for the liver to break down; virtually all of the radioactive I À is excreted by the kidneys. As reported in Elmer (1938) , Scheffer (1937) measured 2.8-9.0% of the total radioactive I À excreted in the feces. They noted that this amount was highly variable. For example, after fasting fecal radioactivity may be undetectable. Braverman and Utiger (1991) stated 'fecal excretion of dietary iodine is negligible' (5 mg/ day). Fecal elimination should be included in future expansion of the model, which will include thyroid hormone metabolism and homeostasis. The rapid urinary clearance of ClO 4 À and radioactive I À , seen in both rats (Yu et al., 2002) and humans (Greer et al., 2002) , was described with a kidney compartment. Urinary clearance could have easily been describe from the free anion portion in the blood; however, significant levels of deiodination occur in the kidneys, which would be critical in future model extrapolations to simulate thyroid hormone metabolism and clearance. Similarly, the liver compartment was maintained separately because it is the major site of extrathyroidal deiodination and it may be required in future pharmacodynamic elaborations of the model. At this point, the inclusions of these compartments did not add a great deal of complexity or uncertainty to the model.
Because both anions are highly hydrophilic, fat acts as an exclusionary compartment. Given the large variability in human body fat, it was important to explore the contribution of this compartment to the overall anion kinetics. In addition, rapidly changing fat content during reproduction made the compartment important for extrapolation across life stages (Clewell et al., 2001 (Clewell et al., , 2003a . The perfusion-limited compartments (e.g., kidney, liver, fat, slowly perfused, and richly perfused) were each described using partition coefficients and blood flows. (Hays and Green, 1973; Scatchard and Black, 1949) . Approximately 95-98% of endogenous plasma iodine is reported as protein-bound iodide (PBI) in human serum (Rapport and Curtis, 1950; Underwood, 1977) . However, unlike bound ClO 4 À , the bound I À fraction primarily represents nonexchangeable, covalently bound, 'incorporated I À ' secreted from the thyroid (e.g., hormonal iodine and iodinated proteins, including tri-and diiodothyronine) rather than simply inorganic I À bound to carrier proteins. In fact, it has been shown that approximately 90% of endogenous PBI represents T 4 and 5% represents T 3 (Berkow et al., 1977) . Michaelis-Menten kinetics were used in the model to describe the association of the free ClO 4 À and I À fractions to unspecific plasma binding sites, and first-order rates were used for their dissociations. In the case of I À , however, dissociation represents both deiodination of hormones and disassociation of I À from serum proteins. Hormone deiodination occurs at several sites throughout the body, but in the absence of better data, it was lumped together as one first-order rate. Although unlabelled I À is not included in the model, the behavior of tracer doses of radioactive I À is expected to follow that of endogenous I À . This is because the average levels of plasma inorganic iodine (PII) are expected to be around 0.40 6 0.23 mg/dl (Elte et al., 1983) , well below the NIS Km value (described below). Therefore, the NIS will not be saturated in the 'average' person.
Model Parameters
Physiological parameters. Tissue volumes and blood flows are presented in Table 1 . Considerable variability was reported for some parameters, such as blood flow to the stomach (QG), which can increase 10-fold in response to enhanced functional activity (secretion and digestion) (Granger et al., 1985) . The blood flows used represent estimates of resting values. Human data on the volume of the stomach capillary bed (VGBc) were not available. Therefore, a value derived from rat stomach data (Altman and Dittmer, 1971a) was allometrically scaled as described below. Mean values reported in the literature were used for all other physical parameters.
Total thyroid volume was obtained from ultrasound measurements on 57 healthy adults conducted by Yokoyama et al. (1986) . Thyroid volume was positively correlated with both body weight and age, with weight having the most pronounced influence. The proportions of the thyroid follicular epithelium, lumen, and stroma were estimated from histometric measurements of patients at necropsy reported by Brown et al. (1986) . Their findings on the histological features of thyroids showed overlapping distributions without evidence of significant differences between sexes. Significant sex differences, however, are Table 2 . These parameters were kept as consistent as possible with those used in the male and pregnant rat models (Clewell et al., 2003b; Merrill et al., 2003) . Across the models, partition coefficients were nearly identical, although differences exist in parameters describing maximum capacities for the nonlinear uptake of the anions. The partitions for the thyroid subcompartments were based on electrical potentials measured within the thyroid stroma, follicular membrane, and lumen after ClO 4 À dosing (Chow and Woodbury, 1970) . Electrical potential differences can be interpreted as effective partition coefficients for charged moieties, such as ClO 4 À and I À , hindering entrance of negatively charged ions from the stroma into the follicle, while the equal and opposite potential from the follicle to the lumen enhances passage of negatively charged species into the lumen and indicates an effective partition coefficient greater than one. Using Chow and Woodbury's measured electrical potentials at the stroma:follicle and follicle:lumen interfaces, effective partitions were calculated, as described in Merrill et al. (2003) . These values were also used to describe the uptake of I À based on the fact that I À and ClO 4 À have the same ionic charge and similar ionic radii and therefore respond similarly to an electrochemical gradient. A M-M affinity constant (KmTF i ) for I À at the NIS of 4.0 3 10 6 ng/l was derived by Gluzman and Niepomniszcze (1983) from human thyroid slices. The authors noted little variation between normal and pathological thyroid Kosugi et al. (1996) , who reported a similar Km value of 4.4 3 10 6 ng/l for I À affinity for NIS in Chinese hamster ovary cells. Therefore, the value reported by Gluzman and Niepomniszcze was also used to describe iodide's affinity in the skin and stomach. Kosugi et al. (1996) also measured perchlorate's affinity for NIS and reported a Km of 1.5 3 10 5 ng/l, approximately ten times lower than the that for I À , indicating a greater affinity for perchlorate. Several other studies agree that perchlorate's affinity for NIS is approximately ten times greater than that of I À (Halmi and Stuelke, 1959; Harden et al., 1968; Lazarus et al., 1974; Wyngaarden et al., 1952) . Based on this information, a KmTF p value was set to 1.6 3 10 5 ng/l, adjusting the literature value slightly based on the model fits to ClO 4 À data in NIS-containing tissues. This values lies between that measured by Kosugi et al. and that required in the corresponding male rat model (1.8 3 10 5 ng/l). The apical membrane of the thyroid follicle also exhibits a selective I À channel, believed to be pendrin. Pendrin is a transmembrane glycoprotein, which facilitates both chloride and I À efflux across the apical membrane (Mian et al., 2001; Scott et al., 1999) . Golstein et al. (1992) measured a Km of 4.0 3 10 9 ng/l, for I À transport from the bovine thyroid follicle into the lumen (KmTL i ). However, as in the corresponding rat model, a slightly lower KmTL i of 1.0 3 10 9 ng/l was required to fit thyroid I À data at later time points (48 h). Golstein et al. (1992) reported that this apical channel also appears sensitive to ClO 4 À inhibition, suggesting a lower Km for ClO 4 À (KmTL p ) than for I À . A KmTL p value of 1.0 3 10 8 ng/l was derived from Chow and Woodbury's (1970) data, as described in Merrill et al. (2003) .
Maximum velocities, Vmax(s), for anion uptake vary between tissues and species (Bagchi and Fawcett, 1973; Wolff, 1998) . Humans tend to have lower Vmax values than other species (Gluzman and Niepomniszcze, 1983; Wolff and Maurey, 1961) when expressed per gram of tissue. The Vmax(s) (ng/h/kg) for I À uptake in the thyroid and plasma were estimated by visually optimizing the clearance portion of the curves to respective time-course data of Degroot et al. (1971) . This was accomplished by keeping all other parameters fixed, while the Vmax value was adjusted so that the model prediction adequately approximated the observed mean. It may be noted that Vmax values for the thyroid follicle and lumen differ by up to an order of magnitude from preliminary values, reported in Clewell et al. (2001) . This was attributed to the availability of new data sets, which allowed improved parameterization. For tissues lacking time-course data, the Vmax(s) were estimated to yield kinetics similar to those described by the male rat model (Merrill et al., 2003) . For example, for I À kinetics in the stomach and skin, VmaxG i and VmaxSk i respectively, were visually optimized to resemble tissue:serum concentration ratios seen in the rat, while maintaining the fits to human serum data. Because ClO 4 À data was only available in serum and urine, ClO 4 À Vmax(s) for NIS-containing tissues were scaled from the I À Vmax(s), using the ratios between corresponding I À and ClO 4 À Vmax(s) established in the male rat model. Diffusion, concurrent with active uptake in the stomach, thyroid, and skin, was described using permeability area cross products (PA) (l/h-kg) and effective partition coefficients (P). In general, PA values were visually fit to the uptake portion of the curves, prior to setting Vmax(s), with partition coefficients, and all other parameters were set to the values in Table 2 Degroot et al. (1971) . The first-order rate, describing the body's overall deiodination rate (Cldeiodc i ) was also estimated through visual optimization of the later PBI timepoints, while maintaining the model fit to total plasma iodine and keeping all other parameters fixed. Later plasma time points of PBI reflect the contribution of hormone secretion and deiodination rates due to sufficient lapse of time for radioactive I À incorporation into thyroid hormones and precursors. Therefore, earlier PBI time points were visually fit to establish parameters for binding of inorganic I À to plasma proteins (e.g., KmB i , VmaxB i ). Similarly, reversible plasma binding of perchlorate was described using a first-order rate constant (Clunb p ), which was visually optimized to available serum ClO 4 À data. Urinary excretion rates for both anions (ClU i and ClU p ) were visually fit to available cumulative urine data (Degroot, 1971; Greer et al., 2002; Hays and Solomon, 1965) . Because cumulative urinary perchlorate data was available in the Greer et al. study, ClU p was visually fit to each individual's data, and the average value was then used for the model parameter. Allometric scaling and rate equations. Differential equations used to simulate radioactive I À and ClO 4 À transport were written and solved in ACSL TM (Advanced Continuous Simulation Language) (AEgis Technologies, Austin, TX). To account for body-weight-dependent variables and species extrapolations, allometric scaling was applied to Vmax(s), PA(s), Cl(s), tissue volumes (V), and blood flows (Q). The variety of dosing regiments and routes were simulated using various pulse function codes in ACSL.
Rate equations describing I À transport in ng/h in the thyroid stroma, follicle and lumen (colloid) (RATS i , RATF i , and RATL i , respectively), as well as the rate of change in bound thyroid iodine (RAbnd i ) are provided below. These equations demonstrate diffusion-limited uptake, using P(s) and PA(s), and saturable uptake and competitive inhibition using M-M parameters. Equations used in the other compartments are expressed similarly. (Merrill et al., 2003) . Sensitivity analysis of parameters. To assess the relative impact of each parameter on model predictions, a sensitivity analysis was performed. After finalizing all model parameters, the model was run at a drinking water dose below NIS saturation (0.1 mg/kg/day) for 240 h (to ensure equilibrium was reached) to determine the average serum ClO 4 À concentration [area under the curve (AUC)]. The model was then repeatedly rerun, using a 1% increase in each parameter to determine the resulting change in predicted serum ClO 4 À concentration AUC, and sensitivity coefficients for each parameter were then calculated using the equation below. 
RESULTS

Model Parameterization
Iodide kinetics. Effective partition coefficients (P) and affinity constants for the active transport mechanisms (Km), listed in Table 2 , were kept consistent with those used in the male rat model. Parameterization of other I À parameters was obtained using available human time-course data as described in the Methods section. Figures 2A through 2D show the model simulations of the early distribution of 131 I À in plasma, thyroid, gastric juice, and urine during both the control and gastric aspiration session by Hays and Solomon (1965) . Degroot's plasma, urine, and thyroid time-course measurements extended nearly 11 days post-dosing, allowing greater calibration of parameters affecting both uptake and clearances in the thyroid and plasma. Model simulations of plasma inorganic I À , PBI, and total plasma iodine are presented in Figures 3A-3C . The model underpredicted urinary I À measured by Degroot et al. (1971) (Fig. 3D) . However, considerable variations in I À excreted by humans exist, as it varies with thyroid function and dietary I À intake (NRC, 1996) . Since increasing urinary clearance (ClU i ) would result in underprediction of plasma iodine, the value for ClU i was not changed to fit this data set.
The subjects from the Hays and Solomon (1965) and Degroot (1971) studies had fasted at least 12 h prior to 131 I À administration. The VmaxTF i values, visually optimized from these data, averaged 2.5 3 10 5 ng/h-kg. Using this value, however, individual 8 and 24 h radioactive I À thyroid uptake (RAIU's) from Greer and coworkers' (2002) study were over-predicted. Since no dietary restrictions were given to the subjects in the Greer study, differences in dietary I À among subjects in the three studies may account for the differences in uptake. Individually fit VmaxTF i values using the Greer (2002) data resulted in a lower average, 1.5 3 10 5 ng/h-kg, reflecting the high iodine intake (see Table 3 and Figure 4) .
Kinetic data for I À in human skin were not available. However, as mentioned earlier, NIS has been identified in human skin (Slominski et al., 2002) . Assumptions that anion uptake and clearance in human skin were comparable to that in rat skin [e.g., slow uptake into and diffusion out of the tissue (Merrill et al., 2003) ] lead to improved fits of serum 131 I À concentrations. Perchlorate kinetics. Because I À parameterization, which was based on actual human time-course data, resulted in many values similar to those developed for the male rat, it is reasonable to expect that the proportional difference between the rat's I À and ClO 4 À parameters would also apply to the human's ClO 4 À parameters. Using these proportionally scaled ClO 4 À parameters for the thyroid, stomach, and skin, cumulative ClO 4 À in urine was visually fit for each individual in the 0.5, 0.1, and 0.02 mg/kg/day dose groups from Greer et al., (2002) , resulting in an average urinary clearance constant for ClO 4 À (ClUc p ) of 0.13 6 0.05 l/h-kg (Table 3) (Fig. 5) .
As mentioned earlier, reversible binding of ClO 4 À to nonspecific human plasma proteins has been qualitatively demonstrated in other studies (Carr, 1952) . Additionally, the model indicated the existence of plasma binding, as without it the model underestimated serum ClO 4 À at 0.1 mg/kg/day, while simulations at 0.5 mg/kg/day produced adequate fits. Hence, at the lower level, plasma binding represents a larger proportion of the overall amount of serum ClO 4 À . Serum levels from the 0.02 mg/kg/ day dose group were below the detection limit and thus could not be compared to model predictions. The plasma protein affinity for ClO 4 À (KmB p ) was assumed to be similar to that used in the male rat model, given the same proteins (albumin and prealbumin) appear to be responsible (Carr, 1952; Merrill et al., 2003) (Fig. 6 ).
Model Validation
The ability of the model to predict human data from other experiments, analyzed at different labs, was tested using available data from other independent studies. Using the parameters in Table 2 , the model slightly overpredicted plasma-bound 131 I À fractions from several euthyroid patients; however, the prediction was remarkably close (within a factor of 0.75 of the mean values reported) (Fig. 7) . Predictions of cumulative ClO 4 À in urine after oral doses of approximately 9.07 mg/kg (Durand, 1938) , 9.56 mg/kg (Kamm and Drescher, 1973) , and 20 mg/kg (Eichler, 1929) were excellent (Figs. 8-10 ).
The model was also able to predict serum ClO 4 À concentrations at 12 mg/kg-day from the unpublished study performed by Dr. Georg Brabant at the Medizinische Hochschule, Hanover, Germany, described previously in the Methods section (Fig. 11) . With the exception of the significantly higher dose, this study was very similar to Greer et al. (2002) . Subjects received 12 mg/kg-day ClO 4 À in drinking water at or near meal times.
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The wide range in the observed serum measurements was believed to reflect variability in the dosing regime, as the experimental protocol was less rigid than that used in Greer et al. (2002) . Table 4 lists the predicted and measured average serum ClO 4 À and percent inhibitions on exposure day 14 from each dose group in Greer et al. (2002) .
The competition of I À and ClO 4 À for NIS binding sites was also successfully predicted by the model. Predictions of thyroid radioactive I À uptake inhibition after 14 days of exposure to ClO 4 À in drinking water at 0.5, 0.1, 0.02, and 0.007 mg/kgday, also measured by Greer et al. (2002) in the same subjects, were well within the mean and standard deviations of the observed data (Figs. 12A-12D ). Using this same set of I À and ClO 4 À parameters, again the model accurately predicted ClO 4 À discharge tests performed by Gray et al. (1972) on euthyroid subjects (Fig. 13) . Lastly, the model's utility for predicting I À and ClO 4 À kinetics under altered thyroid function was evaluated. Hyperthyroidism, (Hays and Solomon, 1965) .
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as manifest in Grave's disease, is marked by increased thyroid I À uptake, as well as elevated T 4 , T 3 , PBI, and TSH (Fenzi et al., 1985) . Gluzman and Niepomniszcze (1983) reported elevated Vmax(s) at the NIS in thyroid specimens from subjects with Grave's disease. As expected, by increasing VmaxcTF i to 5.0 3 10 6 ng/l-kg, the model successfully simulates the thyroidal 131 I À uptake in a male with Grave's disease (upper line in Fig. 14 ) (Stanbury and Wyngaarden, 1952) . This value exceeds those estimated for normal subjects with varying levels of dietary I À by more than a factor of 10. Using this set of thyroid parameters, including the elevated VmaxcTF i , the model underpredicts the degree of inhibition after 100 mg KClO 4 À , but is within a factor of 2 from the data (bottom line Fig. 14) .
Sensitivity Analysis
Sensitivity analysis on serum ClO 4 À AUC levels at 0.1 mg/kg/ day indicated that the urinary clearance (ClU p ) had the greatest influence. The sensitivity coefficient for ClU p was À0.84. Serum ClO 4 À levels at this dose level are also sensitive to plasma binding parameters for maximum capacity (VmaxB p ), the firstorder dissociation rate (Clunb p ), and plasma binding affinity constant (KmB p ), with sensitivity coefficients of 0.26, À0.25, and À0.17, respectively. A comparison of model sensitivity to these parameters between the concurrently developed male rat model and this human model are shown in Figure 15 . Sensitivity coefficients of all other parameters were below an absolute value of 0.1.
DISCUSSION
The validity of the model structure and its parameters are demonstrated by its ability to predict ClO 4 À and I À in serum and urine data, as well thyroid I À inhibition data from various studies, which involve various dose levels and routes, while using a single set of parameters. The model adequately simulates serum and cumulative urine levels after drinking water exposure to ClO 4 À spanning almost four orders of magnitude (0.02 to 12.0 mg/kg-day). Although serum ClO 4 À levels were not available at 0.02 mg/kg-day, the model was able to simulate the cumulative urine from that dose group (Fig. 9) . Comparison with parameters of the rat model indicates that humans have a considerably lower plasma binding capacity (VmaxcB p ) for ClO 4 À (approximately 20 times lower). Although binding of ClO 4 À to plasma proteins has been directly measured in human serum, it is not surprising that it would occur to a lesser extent than in the rat. Carr (1952) tested the ability of ClO 4 À to bind to various proteins
Model simulations (lines) and observed mean 6 SD (bars) 8 and 24 h RAIU measurements from 31 healthy subjects (Greer et al., 2002) . (Greer et al., 2002) . Note: serum perchlorate levels at 0.02 mg/kg/day were below detection limits. (Scott and Reilly, 1954 (Kamm and Drescher, 1973) . 
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37 is expected to be linear over a wide range of doses. Although the mechanism of transfer into the tissues with NIS is saturable, the value of Km (4.0 3 10 6 ng/l) indicates that very high doses would be required to saturate this mechanism. Additionally, similar parameter values and identical model structures in the corresponding rat models of various life stages have yielded validated serum predictions at dose levels ranging three or more orders of magnitude for both anions. Aspects of the model, which were supported in the literature or laboratory studies but could not be directly observed in humans, were incorporated if necessary to improve the fit of the model to available data. For example, active uptake of I À and ClO 4 À into human skin and the relatively slow diffusion of both anions from skin back into systemic circulation were incorporated in spite of a lack of human time-course data. The literature supports this behavior, as NIS has been identified in human skin (Slominski et al., 2002) , and slow diffusion has been noted with similar anions, such as pertechnetate. Hays and Green (1973) performed dialysis studies on intact human tissues with pertechnetate. They found skin had a relatively slow uptake of pertechnetate peaking at 18 h and, in fact, more retention after leaching dialysis than seen in brain, muscle, and serum.
It is possible that the reason elevated I À in human skin has not been reported in clinical radioactive I À scans is the difficulty in differentiating skin radioactivity from background radioactivity. The large volume of the skin allows radioactive I À to be diffused over a large surface. However, this same property allows the skin to be an important pool for the storage and slow turnover of I À . Simulations with this model demonstrated that inclusion of active uptake in human skin was required to simulate serum data. Sensitivity analysis on the corresponding male rat model indicated that serum ClO 4 À levels were highly sensitive to parameters of the skin and plasma binding and urinary excretion (Merrill et al., 2003) .
Kinetic data for establishing parameters for the gastric compartment were limited to the early I À data (3 h post-dosing) by Hays and Solomon (1965) . Their gastric juice 131 I À data indicated rapid transport of I À into the gastric mucosa (Fig. 2C ). It is expected that ClO 4 À uptake in the stomach would behave likewise, due to the similarity of the anions in size and charge. The time-course behavior of radioactive iodine in stomach contents of any species is complicated by the fact that it reflects more than sequestration of radioactive I À by NIS. Its appearance also reflects the accumulation of salivary radioactive I À that is swallowed involuntarily throughout the study. Several studies that examined sequestration of these anions in digestive juices have all shown high variability in the concentrations measured over time (Hays and Solomon, 1965; Honour et al., 1952) . There is a tendency for the gastric juice:plasma ratio to be low when the rate of secretion of gastric juice and saliva is high (Honour et al., 1952) . This is because the increase in secretions does not correspond with upregulation of NIS; therefore, the gastric juice concentration becomes diluted. Fluctuations in the secretion rate are probably the most important factor in determining the pattern of the concentration ratios in individuals. Therefore, variability in stomach or GI tract parameters between models is expected. However, the early rise in the gastric juice:plasma ratio mentioned earlier is a constant feature across these data sets, whether or not an attempt was made to eliminate contamination of gastric juices by dietary contents or saliva. Animal data that show both the anion uptake and clearance in the stomach (Yu et al., 2002) , unlike the data in Figure 2C which only show uptake, indicate that the clearance portion is less rapid. This model, and the series of different life-stage rat models (Clewell et al., 2003a,b; Merrill et al., 2003; ) consistently predict this same trend.
Average urinary clearance values were found to be 0.11 l/h-kg for I À and 0.13 l/h-kg for ClO 4 À . However, these values are not expected to be successfully applied to every euthyroid individual studied, though the use of these average values should provide a reasonable prediction of the euthyroid population. Individual differences in urinary I À are expected with variation in thyroid function and protein-bound I À in plasma. Iodide is ultimately removed or eliminated by two competing mechanisms, thyroidal uptake and urinary excretion. Thus, a higher amount of excreted I À in urine is indicative of reduced thyroid uptake. Historically, this relationship has been used to estimate thyroid function. A cumulative 24-h urinary clearance of less than 30% of a tracer dose is indicative of hyperthyroidism, whereas clearances exceeding 40% are often associated with normal or decreased thyroid function. However, a high degree of variability exists between human subjects. Such a significant degree of overlap exists in thyroid test results for normal, hyperthyroid, and hypothyroid patients, that it is often necessary to run several different additional screens in order to identify subclinical conditions (NRC, 1996) .
In addition to the expected variability in thyroid uptake parameters (VmaxcTF i values ranging from 5.0 3 10 4 to 5.0 3 10 5 ng/h-kg) between individuals, variability across data sets was also noted. However, the difference seen in the average VmaxcTF i obtained from the Greer et al. (2002) subjects (1.5 3 10 5 ng/h-kg) and those from Hays and Solomon (1965) (2.5 3 10 5 ng/h-kg) is easily explained by the difference in experimental conditions between the two studies. Hays and (Greer et al., 2002) .
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Solomon's subjects fasted 12 h prior to the administration of the 131 I À , whereas Greer and coauthors' subjects had no dietary restrictions prior to 125 I À administration. As a result, intrathyroidal I À levels would have been lower in the fasted individuals, and as anticipated, the average VmaxcTF i from Hays and Solomon (1965) would be increased.
Dietary iodine and endogenous inorganic I
À levels are clearly important in modeling I À and ClO 4 À kinetics, because excessive I À levels cause the ion to inhibit its own uptake (Wolff and Chaikoff, 1948) . The ability of the model to describe the bound and free I À fractions in the thyroid and serum provides the basis for subsequent modeling of hormone synthesis and regulation in humans. Measurements of tracer radioactive I À can be fitted to predict transfer rates. However, the use of these acute parameters is limited when attempting to describe long-term thyroid kinetics, unless the existing endogenous I À and the relationships between the regulating hormones are taken into consideration. Ultimately, such factors as preexisting thyroid conditions and regional dietary iodine might be addressed in a more comprehensive hormone feedback model. In its present state, our model is useful in predicting perchlorate's effect on thyroid I
À uptake in what is considered the normal population: euthyroid individuals with adequate dietary I À . That the model is capable of predicting I À uptake in hyperthyroid subjects by increasing the VmaxTF i supports the usefulness of the current model structure. TSH increases the total amount of NIS in a membrane, thereby increasing VmaxTF i . Gluzman and Niepomniszcze (1983) reported elevated Vmax(s) in thyroid specimens from subjects with Graves' disease, toxic adenoma, and dishormonogenetic goiter. In future versions of the model, the increase of TSH and subsequent effect on this parameter can be described mathematically in order to predict the dose-and time-dependent response of the thyroid activity to various disease states. In specimens from nontoxic nodular goiter, Hashimoto's thyroid, or extranodular tissue from toxic adenoma, Vmax(s) were decreased. However, in all subjects there was little variation in the KmT i . Therefore, one would not expect the underprediction of thyroid inhibition in the subject with Graves' disease to be due to disease-induced lowering of FIG. 13 . Model simulation (line) and observed perchlorate discharge tests performed on euthyroid subjects (Gray et al., 1972) . Km, but rather the increased inhibition is mostly likely due to simple interindividual differences. Sensitivity analyses performed on the model for the rat indicates that model-predicted values of inhibition are highly sensitive to even small changes in Km for ClO 4 À . Thus, it is quite possible that changing Km within the range of normal values would account for this apparent discrepancy in the model fit.
The PBPK models developed for perchlorate-induced inhibition have been useful to the ongoing risk assessment of ClO 4 À , and helped integrate the data from diverse data sets to evaluate the dose response of adverse effects from low levels of ClO 4 À exposure (U.S. Environmental Protection Agency, 2003) . The resulting parameters may be used in conjunction with those established for the male (Merrill et al., 2003) and perinatal rat models (Clewell et al., 2003a,b) to extrapolate to human gestational and lactational models (Clewell et al., 2001) . In order to further assess model performance and to facilitate the use of these models in risk assessment, a more comprehensive statistical evaluation of model parameters may prove additionally useful. Sensitivity analysis provided insight into the relative importance of model parameters with respect to specific measures of dose. Comparing the highest sensitivity coefficients between the male rat and human models indicated that, at low doses, human serum ClO 4 À levels are most sensitive to urinary clearance, whereas the rat's serum levels are more sensitive to plasma binding parameters (Fig. 15) (Merrill et al., 2003) . The fact that data was available across multiple doses for establishing parameter values for urinary clearance and plasma binding adds confidence to the model's predictive ability. More useful to the application of the models, for human dosimetry predictions, is variability analysis that is performed with known distributions for model parameters. This tool can be applied to the model to allow the prediction of likely ranges of the dosimetrics within a human population.
Modeled effects on hormone regulation are yet to be developed. Perturbations in hormones levels after ClO 4 À exposure demonstrate complex differences in the hormone regulatory mechanisms between rats and humans, which are difficult to describe (Clewell et al., 2001; Merrill et al., 2001) . However, the current model structures may provide a basis for evaluating thyroid effects from other environmental contaminants. For example, excessive exposure to other similarly behaving anions, such as sodium chlorate, thiocyanate, or nitrate, all found to also contaminate ground and surface waters, may contribute to environmental anti-thyroid effects in humans (Hooth et al., 2001; Wolff and Maurey, 1963) . Further, the possibility of additive anti-thyroid effects to those of perchlorate from these cocontaminants may need to be considered (Kahn et al., 2004) .
